| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/25/2002 | WO2002032931A2 Haplotypes of the fos gene |
| 04/25/2002 | WO2002032930A2 Haplotypes of the scya21 gene |
| 04/25/2002 | WO2002032929A2 Haplotypes of the cer1 gene |
| 04/25/2002 | WO2002032928A2 Haplotypes of the hrh1 gene |
| 04/25/2002 | WO2002032926A2 Haplotypes of the ccbp2 gene |
| 04/25/2002 | WO2002032920A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/25/2002 | WO2002032568A1 Particulate support for separation/purification or extraction and process for producing the same |
| 04/25/2002 | WO2002032559A1 Paste, which can undergo screen printing, for producing a porous polymer membrane for a biosensor |
| 04/25/2002 | WO2002032419A2 Methods for modulating bladder function |
| 04/25/2002 | WO2002032397A2 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | WO2002032291A2 Imaging of enzymatic activity |
| 04/25/2002 | WO2002032288A2 Cd38 modulated chemotaxis |
| 04/25/2002 | WO2002032286A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2001092563A3 Method for detecting a detectable product |
| 04/25/2002 | WO2001088136A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2001079229A3 Haplotypes of the cxcr4 gene |
| 04/25/2002 | WO2001075072A3 Production of TcR gamma delta T cells |
| 04/25/2002 | WO2001068907A3 Stable expression of polymorphous forms of human cytochrome P450 2D6 |
| 04/25/2002 | WO2001068880A3 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 04/25/2002 | WO2001062963A3 Method for immobilizing nucleic acids |
| 04/25/2002 | WO2001061041A3 Multiple-site reaction device and method |
| 04/25/2002 | WO2001061010A3 GTPASE activating proteins |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001060174A3 Weight loss induced by reduction in neuropeptide y level |
| 04/25/2002 | WO2001059453A3 Biosensor compositions and methods of use |
| 04/25/2002 | WO2001057241A3 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers |
| 04/25/2002 | WO2001057240A3 Interaction of nmda receptor with protein tyrosine phosphatase |
| 04/25/2002 | WO2001057235A3 Analysis of catalysed reactions by calorimetry |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | WO2001040517A3 Evaluating and predicting clinical outcomes by gene expression analysis |
| 04/25/2002 | WO2001038586A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/25/2002 | WO2001038580A3 Nucleic acid probe arrays |
| 04/25/2002 | WO2001038577A3 Human transcriptomes |
| 04/25/2002 | WO2001031017A3 Plants with a modified flower and seed development |
| 04/25/2002 | WO2001020040A3 Method and compositions for evaluating resolution of nucleic acid separation systems |
| 04/25/2002 | WO2000029622A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/25/2002 | US20020049998 Cytoplasmic male sterility system production canola hybrids |
| 04/25/2002 | US20020049987 Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof |
| 04/25/2002 | US20020049545 Amino acid frame indication system, method for amino acid frame indication, and recording medium |
| 04/25/2002 | US20020049543 Method for displaying gene experiment data |
| 04/25/2002 | US20020049302 Purification of preferential lymphocytes; incubate modulator with cells, detect lymphocytes expressing detectable markers |
| 04/25/2002 | US20020049301 For therapy of cancer, diabetes, obesity, diseases of the central nervous system, inflammatory disorders, autoimmune dieseases cardiovascular diseases, for generating antibodies |
| 04/25/2002 | US20020049177 Detecting an aberrant level or bioactivity of or screening for a Wnt pathway component or a frizzled related protein gene product |
| 04/25/2002 | US20020049167 Azithromycin as a therapeutic agent for infections with leishmania parasites |
| 04/25/2002 | US20020049151 Therapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors |
| 04/25/2002 | US20020048809 Capillary array-based sample screening |
| 04/25/2002 | US20020048801 Peptide with enzymatic activity; for use as diagnostic tools in detecting cancer and cardiovascular and liver disorders |
| 04/25/2002 | US20020048800 Myosin-like gene expressed in human heart and muscle |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048785 Novel polypeptides within the tumor necrosis factor receptor superfamily and uses therefor |
| 04/25/2002 | US20020048780 Monitoring propagation of microorganism in broth; obtain broth, flow fluid through filter, place filter on plate, incubate with nutrients, screen for propagation of microorganism |
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048771 Isolating preferential nucleotide sequences in sample; obtain sample, incubate with probes, heat, cool, extract denatured nucleotide sequences |
| 04/25/2002 | US20020048769 Protein-protein interactions in neurodegenerative disorders |
| 04/25/2002 | US20020048767 Detecting genomic position of preferential genes; obtain nucleotide sequences, incubate with probes, determine distance, positioning and size of probe in genome |
| 04/25/2002 | US20020048766 Method and system for the multidimensional morphological reconstruction of genome expression activity |
| 04/25/2002 | US20020048764 Human PEM as a target for birth contol and treatment of Alzheimer's disease |
| 04/25/2002 | US20020048763 Nucleotide sequences for use in the detection of transcription patterns in preferential tissues |
| 04/25/2002 | US20020048762 Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms |
| 04/25/2002 | US20020048761 Molecular cloning using rolling circle amplification |
| 04/25/2002 | US20020048760 Use of mismatch cleavage to detect complementary probes |
| 04/25/2002 | US20020048759 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |
| 04/25/2002 | US20020048758 Carrier for gene detection and its use for detecting validity of interferon therapy |
| 04/25/2002 | US20020048757 Simple and quick method for determining the nucleotide sequence of a mitochondrial 21S ribosomal RNA gene of yeast belonging to Saccharomyces cerevisiae |
| 04/25/2002 | US20020048756 Monitoring gene expression patterns; obtain sample, extract nucleotide sequences, amplify nucleotide sequences, recover preferential amplified nucleotide sequences |
| 04/25/2002 | US20020048755 Screening drugs for health efficiency; obtain drug, expose to diagnostic testing, expose to humans, monitor activity in humans, monitor health of humans |
| 04/25/2002 | US20020048753 Utiliztion of probes for sequence determination; obtain sample, generate probes, mix, hybridize, amplify nucleotide sequences, separate nucleotide sequences by electrophoresis, monitor and compare electrophoretic patterns |
| 04/25/2002 | US20020048752 Screening for preferential nucleotide sequences in sample; generate probe, incubate with sample, anneal, detect signal from probes |
| 04/25/2002 | US20020048751 Microarray for use in the detection of preferential particles in sample |
| 04/25/2002 | US20020048749 Methods for polymorphism identifcation and profiling |
| 04/25/2002 | US20020048610 High-throughput formation, identification, and analysis of diverse solid-forms |
| 04/25/2002 | US20020048582 Methods of modulating angiogenesis |
| 04/25/2002 | US20020048531 Deposited thin films and their use in detection, attachment, and bio-medical applications |
| 04/25/2002 | DE10052526A1 Composition for detecting nucleic acid mutations, comprises two groups of nucleic acid attached to flanking sequences that can form distinguishable hetero- and homo-hybrids |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464092A1 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | CA2426403A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2426196A1 Simultaneous quantification of nucleic acids in diseased cells |
| 04/25/2002 | CA2426172A1 Nucleic acid amplification controls |
| 04/25/2002 | CA2426126A1 A urine test for the diagnosis of prion diseases |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425873A1 Imaging of enzymatic activity |
| 04/25/2002 | CA2425807A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 04/25/2002 | CA2425763A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | CA2425742A1 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | CA2425723A1 Neuromedin u delta |
| 04/25/2002 | CA2425669A1 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | CA2425605A1 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/25/2002 | CA2425174A1 Human gene critical to fertility |
| 04/25/2002 | CA2424643A1 Cd38 modulated chemotaxis |
| 04/25/2002 | CA2423596A1 Assays |
| 04/24/2002 | EP1199567A1 E. coli agglutination assay |
| 04/24/2002 | EP1199564A2 A method for screening substances for effect on intracellular translocation |
| 04/24/2002 | EP1199372A2 Polymorphisms in the human P2X7 gene |
| 04/24/2002 | EP1199371A2 Methods for identifying products employing reporter gene expression |
| 04/24/2002 | EP1199360A2 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor |
| 04/24/2002 | EP1199359A1 Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds |
| 04/24/2002 | EP1199358A1 Gene encoding promoter domain of tumor suppressor gene p51 and use thereof |